The North America antihypertensive drugs market is predicted to record a CAGR of 3.28% during the forecast years of 2019 to 2028. The existence of key players like Merck & Co., and Johnson & Johnson, and a surge in the prevalence of hypertension and chronic kidney diseases sustains the market growth in the region. The North America antihypertensive drugs market growth is evaluated across the United States and Canada.

NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET 2019-2028

North America Antihypertensive Drugs Market by Drug Class (Calcium Channel Blockers, Ace Inhibitors, Beta-adrenergic Blockers, Diuretics, Vasodilators, Other Drug Class) by End-user (Hospital Pharmacy, Retail Pharmacy, E-commerce Websites & Online Drug Stores) and by Geography.

Request free sample

The North America antihypertensive drugs market is predicted to record a CAGR of 3.28% during the forecast years of 2019 to 2028. The existence of key players like Merck & Co., and Johnson & Johnson, and a surge in the prevalence of hypertension and chronic kidney diseases sustains the market growth in the region.
North America Antihypertensive Drugs Market

To know more about this report, request a free sample copy.

The North America antihypertensive drugs market growth is evaluated across the United States and Canada. The United States registered the largest revenue share in 2019, due to the prevalence of hypertension in the country. The upsurge in the geriatric population leads to an increased need for antihypertensive drugs as they are more susceptible to chronic kidney diseases and hypertension. For instance, the population above the age of 65 in America rose to over 49 million in 2016. This number is estimated to almost double by the year 2060. Antihypertensive drugs are also readily available in the region. The accessibility, in addition to a rise in healthcare expenditure, has considerably propelled the market growth. In Canada, it is predicted that the overall health expenditure will represent over 11% of the country’s gross domestic product (GDP). The upswing in healthcare expenses is set to drive the antihypertensive drugs market during the forecast period.

With its headquarters in the United States, Aspire Bariatrics is a medical device company, recognized for revolutionizing the treatment for obesity through its non-invasive weight loss system called AspireAssist. The enterprise is supported by a commercial infrastructure that facilitates the distribution of high quality and economical products and services, catering to the needs of patients worldwide.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • MARKET DEFINITION
      •    KEY DRIVERS
        • GROWING PREVALENCE OF HYPERTENSION ACROSS THE GLOBE
        • SURGE IN DISPOSABLE INCOME AND HEALTHCARE SPENDING
        • RISING AGING POPULATION
      •    KEY RESTRAINTS
        • PATENT EXPIRATIONS
        • DELAY IN PRODUCT LAUNCHES
    1. KEY ANALYTICS
      •    PORTER’S FIVE FORCE ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYER’S POWER
        • SUPPLIER’S POWER
        • COMPETITIVE RIVALRY
      • REGULATORY FRAMEWORK
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY INVESTMENT INSIGHTS
    2. MARKET BY DRUG CLASS
      • CALCIUM CHANNEL BLOCKERS
      • ACE INHIBITORS
      • BETA-ADRENERGIC BLOCKERS
      • DIURETICS
      • VASODILATORS
      • OTHER DRUG CLASS
    3. MARKET BY END-USER
      • HOSPITAL PHARMACY
      • RETAIL PHARMACY
      • E-COMMERCE WEBSITES & ONLINE DRUG STORES
    4. GEOGRAPHICAL ANALYSIS
      •    NORTH AMERICA
        • THE UNITED STATES
        • CANADA
    1. COMPANY PROFILES
      • ALLERGAN PLC
      • ASPIRE BARIATRICS INC
      • ASTRAZENECA PLC
      • BIO-RAD LABORATORIES INC
      • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • DAIICHI SANKYO COMPANY LIMITED
      • HILL-ROM HOLDINGS INC
      • JOHNSON & JOHNSON
      • LUPIN LIMITED
      • MEDTRONIC PLC
      • MERCK & CO INC
      • NOVARTIS AG
      • PFIZER INC
      • SANOFI
      • SUN PHARMACEUTICAL INDUSTRIES LTD (RANBAXY LABORATORIES)

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – ANTIHYPERTENSIVE DRUGS

    TABLE 2: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 3: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 4: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 5: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 7: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    FIGURE LIST

    FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 2: OPPORTUNITY MATRIX

    FIGURE 3: VENDOR LANDSCAPE

    FIGURE 4: KEY INVESTMENT INSIGHTS

    FIGURE 5: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY DRUG CLASS, IN 2019

    FIGURE 6: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY CALCIUM CHANNEL BLOCKERS, 2019-2028 (IN $ MILLION)

    FIGURE 7: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY ACE INHIBITORS, 2019-2028 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY BETA-ADRENERGIC BLOCKERS, 2019-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY DIURETICS, 2019-2028 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY VASODILATORS, 2019-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY OTHER DRUG CLASS, 2019-2028 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY END-USER, IN 2019

    FIGURE 13: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY HOSPITAL PHARMACY, 2019-2028 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY RETAIL PHARMACY, 2019-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, BY E-COMMERCE WEBSITES & ONLINE DRUG STORES, 2019-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

    FIGURE 17: THE UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 18: CANADA ANTIHYPERTENSIVE DRUGS MARKET, 2019-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    NORTH AMERICA
        • THE UNITED STATES
        • CANADA
    1. MARKET BY DRUG CLASS
      • CALCIUM CHANNEL BLOCKERS
      • ACE INHIBITORS
      • BETA-ADRENERGIC BLOCKERS
      • DIURETICS
      • VASODILATORS
      • OTHER DRUG CLASS
    2. MARKET BY END-USER
      • HOSPITAL PHARMACY
      • RETAIL PHARMACY
      • E-COMMERCE WEBSITES & ONLINE DRUG STORES

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type